humera is in the process of coming off patent where we'll see lower cost for humera, it has to run its course through, the manufactures legal attempts to you know. but it's, so i guess long story short, most of your members don't require these drugs. one percent of your members do in this plan and just because of the cost of the medications, it's almost half of the planned cost. >> i think, we had good educational experiences regarding medication cost and these specialty drugs and this is a big deal. i'm assuming that the capping of insulin will have zero o februarying. so we need to focus on the real issue not as the importance of the capping of insulin. this data is truly alarming to me, because it's a tsunami affect of people who delayed diagnosis, and maybe that is a, that is a to some extent, the drop in hypertension rates in the bsc plans but everything else went way up. and ien childbirth in terms of a lot of women getting their prenatal care have these other conditions whether it's bmi that is too high or diabetes or hypertension, if this is a tsunami affect, maybe this is less